The experimental background in the pioneer study of Viale et al. in 2014 [28] was that of cells surviving genetic ablation of the Kras oncogene responsible for tumor relapse and relying on mitochondrial respiration to survive, whereas our experimental model implementing drug treatments is a true context of persistence supported by drug tolerance. Here, KRAS is linked to neoplasm.